Michelle H. Zhang

Michelle H. Zhang

Auto-generated profile, based on publicly available information

Michelle H. Zhang

Department of Otolaryngology—Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2021 in Infancy
Verified
Journal Article
Closed access
PDF file
ASAlexis S. Smith‐Flores
Alexis S. Smith‐Flores
JPJasmin Perez
Jasmin Perez
MZMichelle H. Zhang
Michelle H. Zhang
LFLisa Feigenson
Lisa Feigenson

1 January 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
Urvish PatelUrvish Patel
Urvish Patel
MZMichelle H. Zhang
Michelle H. Zhang
KPKaran Patel
Karan Patel
PMPreeti Malik
Preeti Malik
MSMansi Shah
Mansi Shah
ALAbhishek Lunagariya
Abhishek Lunagariya
Patel UK, et al. J Clin Neurol. 2020 Apr;16(2):191-201. https://doi.org/10.3988/jcn.2020.16.2.191

5 September 2019 in Cureus
Verified
Journal Article
Open access
PDF file
LLLiseth K. Lavado
Liseth K. Lavado
MZMichelle Zhang
Michelle Zhang
KPKaran Patel
Karan Patel
SKSohim Khan
Sohim Khan
Urvish PatelUrvish Patel
Urvish Patel
Alzheimer’s Disease (AD) is a debilitating neurodegenerative disease that is diagnosed by gradual memory loss and certain cognitive impairments involving attention, reasoning, and language. Most of the research on Alzheimer’s disease focuses on the correlation of its neuropathological changes in the neurofibrillary tangles caused by hyper-phosphorylated tau protein and β-amyloid plaques with respect to cognitive impairment. Its pathology, however, remains incompletely understood. Currently, research has demonstrated that environmental factors such as biometals play a crucial role in exacerbating AD progression. The present review examines the role of metals in AD progression and how metal dyshomeostasis attributes to AD pathogenesis. It was found that certain metals possess both beneficial and harmful properties in terms of AD progression. Depending upon the concentration of the metal of interest, copper, zinc, iron, and selenium have general beneficial properties. However, when present in excess, they can lead to oxidative stress and hyperphosphorylation of tau protein, amongst other harmful effects, while calcium and magnesium were seen to have beneficial effects by regulating biometal uptake. In this review, we have provided evidential studies that focus on the involvement of certain metals in antioxidant pathways leading to the formation of reactive species indicative of neurodegeneration.

18 July 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KBKaterina L. Byanova
Katerina L. Byanova
JFJessica Fitzpatrick
Jessica Fitzpatrick
AJAmanda K. Jan
Amanda K. Jan
MMMaggie McGing
Maggie McGing
MHMarlena Hartman-Filson
Marlena Hartman-Filson
LHLaurence Huang
Laurence Huang
Objectives: An isolated reduction in the diffusing capacity for carbon monoxide (DLco; iso↓DLco) is one of the most common pulmonary function test (PFT) abnormalities in people living with HIV (PWH), but its clinical implications are incompletely understood. In this study, we explored whether iso↓DLco in PWH is associated with a greater respiratory symptom burden. Study design: Cross-sectional analysis Methods: We used ATS/ERS compliant PFTs from PWH with normal spirometry (post-bronchodilator FEV1/FVC ≥0.7; FEV1, FVC ≥80% predicted) from the I AM OLD cohort in San Francisco, CA and Seattle, WA, grouped by DLco categorized as normal (DLco ≥lower limit of normal, LLN), mild iso↓DLco (LLN >DLco >60% predicted), and moderate-severe iso↓DLco (DLco ≤60% predicted). We performed multivariable analyses to test for associations between DLco and validated symptom-severity and quality of life questionnaires, including the modified Medical Research Council dyspnea scale (mMRC), the COPD Assessment Test (CAT), and St. George’s Respiratory Questionnaire (SGRQ), as well as between DLco and individual CAT symptoms. Results: Mild iso↓DLco was associated only with a significantly higher SGRQ score. Moderate-severe iso↓DLco was associated with significantly higher odds of mMRC ≥2 and significantly higher CAT and SGRQ scores. PWH with moderate-severe iso↓DLco had increased odds of breathlessness, decreased activity, lower confidence leaving home, and less energy. Conclusions: Iso↓DLco is associated with worse respiratory symptom scores, and this association becomes stronger with worsening DLco, suggesting that impaired gas exchange alone has a significant negative impact on the quality of life in PWH. Additional studies are ongoing to understand the etiology of this finding and design appropriate interventions.

1 October 2025 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
MZMichelle H. Zhang
Michelle H. Zhang
JFJessica Fitzpatrick
Jessica Fitzpatrick
JBJake Branchini
Jake Branchini
KBKaterina L. Byanova
Katerina L. Byanova
RARebecca Abelman
Rebecca Abelman
LHLaurence Huang
Laurence Huang
Rationale: The most common lung function abnormality in people with human immunodeficiency virus (HIV) (PWH) is a low diffusing capacity of the lung for carbon monoxide (Dl CO), which is associated with distinct plasma biomarker patterns, increased symptom burden, and increased mortality. In PWH undergoing spirometry and Dl CO measurement, the most common abnormality is an abnormal Dl CO with normal spirometry (iso↓Dl CO), which is associated with distinct biomarkers and increased symptom burden but whose association with mortality is unknown. Objectives: To investigate the relationship between abnormal Dl CO, including iso↓Dl CO, and mortality in PWH. Methods: Adult PWH underwent pre and postbronchodilator spirometry and single-breath Dl CO measurements from April 2013 to January 2023. Dl CO was categorized as normal (Dl CO greater than or equal to the lower limit of normal [LLN]), mildly abnormal (60% predicted < Dl CO < LLN), or moderately to severely abnormal (Dl CO ≤60% predicted). Iso↓Dl CO was defined as abnormal Dl CO with normal spirometry (forced expiratory volume in 1 second/forced vital capacity ≥ LLN, forced expiratory volume in 1 second ≥ LLN, forced vital capacity ≥ LLN). Participants’ present vital status was assessed through electronic health record review and the National Death Index. Multivariable Cox proportional hazards models adjusted for age, smoking status, history of bacterial pneumonia, and CD4 count were used to estimate associations between Dl CO and all-cause mortality. Results: Among 241 participants, 205 (85%) were male and 26 (11%) died during follow-up of 1,055 person-years. Among 178 participants with normal spirometry, 16 (9%) died over 770 person-years. Both moderate to severe Dl CO impairment (adjusted hazard ratio, 4.67; 95% confidence interval, 1.69–12.9; P = 0.003) and moderate to severe iso↓Dl CO (adjusted hazard ratio, 11.0; 95% confidence interval, 2.20–55.1; P = 0.004) were significantly associated with increased mortality. Conclusions: Moderate to severe impairment of Dl CO and iso↓Dl CO are associated with all-cause mortality in PWH. Further studies evaluating mechanistic pathways and cause-specific mortality are warranted.

19 January 2026 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
LKLourdes Kaufman
Lourdes Kaufman
MZMichelle H. Zhang
Michelle H. Zhang
ASAmritpal Singh
Amritpal Singh
HAHasan Abdulbaki
Hasan Abdulbaki
RLRebecca M. Lewis
Rebecca M. Lewis
NJNicole T. Jiam
Nicole T. Jiam